Quick Answer
Autolus Therapeutics plc reported Operating Income of -$270.54 million for fiscal year 2025.
Autolus Therapeutics plc Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$270.54M | -12.1% |
| 2024 | -$241.43M | -34.3% |
| 2023 | -$179.70M | -25.3% |
| 2022 | -$143.41M | -1.7% |
| 2021 | -$141.05M | +16.1% |
| 2020 | -$168.15M | -15.1% |
| 2019 | -$146.06M | -153.9% |
| 2018 | -$57.53M | -145.7% |
| 2017 | -$23.42M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$71.62M | -5.5% | -17.0% |
| June 30, 2025 | -$61.22M | -3.9% | +6.2% |
| March 31, 2025 | -$65.24M | -68.3% | +3.9% |
| September 30, 2024 | -$67.88M | -58.2% | -15.2% |
| June 30, 2024 | -$58.93M | -32.8% | -52.0% |
| March 31, 2024 | -$38.76M | +1.0% | +9.7% |
| September 30, 2023 | -$42.91M | +1.4% | +3.3% |
| June 30, 2023 | -$44.38M | — | -13.4% |
- Autolus Therapeutics plc showed a decrease of -12.1% in Operating Income compared to the prior fiscal year.
- Over the 2017–2025 period, Autolus Therapeutics plc’s operating income has declined by 1055.3% (from -$23.42 million to -$270.54 million).
- The most recent figure is from Autolus Therapeutics plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: